Print Page

NIHTB-CB Measures Cognitive Change in Intellectual Disability

Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental Disability

Published: 2022/12/05 - Updated: 2023/09/28
Author: University of California - Davis Health - Contact: ucdavis.edu
Peer-Reviewed: Yes - Publication Type: Instructive / Helpful
Journal Reference: DOI Link to the Study Paper
Related Papers: Latest Items - Full List

On This Page: Summary - Defining NIH Toolbox Cognition Battery (NIHTB-CB) - Main Article - About/Author

Synopsis: Research reveals NIH Toolbox Cognition Battery (NIHTB-CB) sensitive to developmental changes in children, teens and young adults. Intellectual disability is characterized by an IQ of about 70 or lower. It affects 1.8 - 3.2% of people worldwide and can occur with conditions such as fragile X syndrome, autism, and Down syndrome. People with lower developmental abilities are often excluded from research studies and clinical trials. That means the results of those studies do not apply to everyone, and this entire group is left out of having the potential benefit of a treatment.

Definition

NIH Toolbox Cognition Battery (NIHTB-CB)

The NIH Toolbox is an initiative of the Neuroscience Blueprint, a collaborative framework through which 16 NIH Institutes, Centers, and Offices jointly support neuroscience-related research to accelerate discoveries and reduce the burden of nervous system disorders. The NIH Toolbox for the Assessment of Neurological Behavior and Function Cognition Battery (NIHTB-CB) is also a common data element (CDE) for use in individuals with traumatic brain injury (TBI).

Main Digest

Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental Disability.

Finding better ways to measure the cognitive change in people with intellectual disability.

advertisement

A major challenge in testing new therapies for people with an intellectual disability is finding accurate tools to measure whether the intervention or medication works. A new study by researchers at the UC Davis MIND Institute and other institutions suggests that the NIH Toolbox Cognition Battery (NIHTB-CB) is a promising option. The study found the test sensitive to developmental changes in children, teens, and young adults.

"People with lower developmental abilities are often excluded from research studies and clinical trials," explained David Hessl, professor in the Department of Psychiatry and Behavioral Sciences and corresponding author of the paper. "That means the results of those studies do not apply to everyone, and this entire group is left out from having the potential benefit of a treatment."

Intellectual disability is characterized by an IQ of about 70 or lower. It affects 1.8 - 3.2% of people worldwide and can occur with conditions such as fragile X syndrome, autism and Down syndrome. Intellectual disability also presents with adaptive behavior challenges. It affects academic achievement, independence, and many aspects of daily life.

What is the NIH Toolbox Cognition Battery?

The NIHTB-CB is a computer or tablet-administered test. It includes a series of brief tasks to assess cognitive functions like attention, working memory, and language.

For example, there is a section that requires participants to compare two pictures and decide if they're the same or different, and another that involves listening to a word and then pointing to the picture that goes with the word. Another section includes listening to a story and then putting images from the tale in the right order.

Measuring Developmental Change in Young People

To assess whether the NIHTB-CB is sensitive to developmental change, the team studied young people during childhood and early adulthood - a time when kids and teens are usually developing cognitive skills and gaining abilities.

"We knew that a substantial portion of young people would be making gains in cognition during this period, and we could use that opportunity to see if the Toolbox picked up on those developmental changes," said Hessl, who is also a MIND Institute faculty member. "Before using a measure in clinical trials, it is important to learn whether it is sensitive to change."

Researchers administered the NIHTB-CB to 256 individuals. Participants were in three groups: those with fragile X syndrome, those with Down syndrome, and those with other intellectual disabilities. The participants ranged in age from 6-27 years. After two years, the team re-tested 197 of the participants.

To cross-validate the NIHTB-CB, the team also administered the Stanford-Binet Intelligence Scales, Fifth Edition (SB5) at both time points. The SB5 is a long-established IQ test.

Results Very Promising

Overall, the developmental growth measured by the NIHTB-CB tests was similar to - or exceeded - that of the SB5. Each group's pattern of NIHTB-CB growth also corresponded to the SB5 growth pattern.

The NIHTB-CB showed significant gains in almost all areas in participants with other intellectual disabilities at age 10, continued gains at 16, and stable development at age 22.

The participants with fragile X syndrome showed delayed gains in attention and inhibitory control compared to the group with other intellectual disabilities. The participants with Down syndrome had delayed gains in receptive vocabulary compared to the group with other intellectual disabilities.

Unlike the other groups, the participants with Down syndrome had significant growth in early adulthood in the areas of attention and inhibitory control, and working memory.

All three groups had very little growth in cognitive flexibility - the ability to adapt to a new rule or environment.

"These findings may help to guide us in terms of where intervention would be the most effective or beneficial," Hessl said.

A New Measurement Tool for Clinical Trials?

Many researchers dislike repeating an IQ test like the SB5 over a short period, as is often required for treatment studies.

"There can be practice effects for some IQ test components, as well as an emphasis on acquired knowledge-type questions," Hessl explained. "For an outcome measure, you want something with more fluid and easily changeable components, like the NIHTB-CB."

Some treatment studies already use the NIHTB-CB to measure cognitive growth. That includes a small, high-profile study that found an Alzheimer's drug increased cognitive scores in adult males with fragile X syndrome. A larger trial is now planned. Hessl is a consultant on the study of the drug company involved, Tetra Therapeutics.

Hessl notes that other possible directions for the NIHTB-CB include adapting it for use in clinics or schools to assess patients or students.

"I think we have strong evidence that the NIH Toolbox Cognition Battery does detect changes in cognition over time. It's not universal - not for every single subtest with all the groups that we studied - but there was enough evidence across the groups and the different tests that it's picking up on some important elements of change," Hessl said.

About the Research

The research was published online on Dec. 2 in Neurology®, the medical journal of the American Academy of Neurology. For a complete list of coauthors, please see the publication.

The study was funded by The National Institute of Child Health and Human Development (R01HD076189), Health and Human Services Administration of Developmental Disabilities (90DD0596), and by the MIND Institute Intellectual and Developmental Disabilities Research Center (P50HD103526).

Attribution/Source(s):

This peer reviewed instructive / helpful article relating to our Cognitive Disabilities section was selected for publishing by the editors of Disabled World due to its likely interest to our disability community readers. Though the content may have been edited for style, clarity, or length, the article "NIHTB-CB Measures Cognitive Change in Intellectual Disability" was originally written by University of California - Davis Health, and published by Disabled-World.com on 2022/12/05 (Updated: 2023/09/28). Should you require further information or clarification, University of California - Davis Health can be contacted at ucdavis.edu. Disabled World makes no warranties or representations in connection therewith.

Share This Information To:
𝕏.com Facebook Reddit

Discover Related Topics:

advertisement

Information, Citing and Disclaimer

Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page.


Permalink: <a href="https://www.disabled-world.com/disability/types/cognitive/nihtb-cb.php">NIHTB-CB Measures Cognitive Change in Intellectual Disability</a>


Cite This Page (APA): University of California - Davis Health. (2022, December 5). NIHTB-CB Measures Cognitive Change in Intellectual Disability. Disabled World. Retrieved September 30, 2023 from www.disabled-world.com/disability/types/cognitive/nihtb-cb.php

Disabled World provides general information only. The materials presented are never meant to substitute for qualified professional medical care, nor should they be construed as such. Funding is derived from advertisements or referral programs. Any 3rd party offering or advertising does not constitute an endorsement.